home / stock / tyme / tyme news

TYME News and Press, Tyme Technologies Inc. From 02/04/21

Stock Information
Company Name: Tyme Technologies Inc.
Stock Symbol: TYME
Market: NASDAQ
Website: tymeinc.com
Menu
TYME TYME Quote TYME Short TYME News TYME Articles TYME Message Board
Get TYME Alerts

News, Short Squeeze, Breakout and More Instantly...
TYME - TYME Announces $100 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs TM ), today announced that it has entered into definitive agreements with several healthcare-focused institutional and other institutional investors for the ...
TYME - VXRT, GWPH, OCGN and SAVA among midday movers

Gainers: Tyme Technologies (TYME) +93%.Sino-Global Shipping America (SINO) +81%.Lizhi (LIZI) +70%.Cassava Sciences (SAVA) +48%.GW Pharmaceuticals (GWPH) +46%.CPS Technologies (CPSH) +41%.10X Capital Venture Acquisition (VCVC) +38%.Naked Brand (NAKD) +37%.SuperCom (SPCB) +34%.Am...

TYME - Why Tyme Technologies Stock Is Crushing It Today

Shares of Tyme Technologies (NASDAQ: TYME) were skyrocketing 84.9% higher as of 12:09 p.m. EST on Wednesday after rising as much as 174% earlier in the day. This huge gain came after the company announced that the U.S. Patent and Trademark Office (USPTO) had granted another patent r...

TYME - Tyme Technologies, GW Pharmaceuticals leads healthcare gainers; Vaxart, Moleculin Biotech among major losers

Gainers: Tyme Technologies (TYME) +110%, GW Pharmaceuticals (GWPH) +47%, Zynerba Pharmaceuticals (ZYNE) +39%, SELLAS Life Sciences (SLS) +38%, InMed Pharmaceuticals (INM) +15%.Losers: Vaxart (VXRT) -51%, Moleculin Biotech (MBRX) -26%...
TYME - Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections

Tyme Technologies (TYME) rallied 89% in premarket trade after it received notification that the U.S. Patent and Trademark Office granted additional patent claims related to the company's metabolomic technology platform which is directed to methods for treating COVID-19.Unlike immune...

TYME - TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the...

TYME - ACRX, ZOM, DDD and JAGX among midday movers

Gainers: ArcLight Clean Transition (ACTCU) +80%.VOXX International (VOXX) +47%.BIOLASE (BIOL) +43%.Dolphin Entertainment (DLPN) +41%.ENGlobal (ENG) +39%.Zomedica (ZOM) +39%.IRIDEX (IRIX) +34%.AcelRx Pharmaceuticals (ACRX) +28%.La Jolla Pharmaceutical (LJPC) ...
TYME - Zomedica, IRIDEX leads healthcare gainers; Avinger, TransEnterix among major losers

Gainers: Zomedica (ZOM) +36%,  IRIDEX (IRIX) +34%, Biomerica (BMRA) +32%, La Jolla Pharmaceutical (LJPC) +29%, Tyme Technologies (TYME) +15%.Losers: Avinger (AVGR) -17%, TransEnterix (TRXC) -16%, PolarityTE (PTE) -14%, ...

TYME - CHU, CHL, FUBO and SKLZ among premarket gainers

Aileron Therapeutics (ALRN) +73%.Broadway Financial Corporation (BYFC) +55% after regulatory approvals for merger with CFBanc Corporation.Atlantic American Corporation (AAME) +43%.Marker Therapeutics (MRKR) +30% after FDA lifted the partial clinical hold on it's Phase 2 trial.Cyclo ...

TYME - AU, GFI, FLIR and MARA among premarket gainers

Ocugen (OCGN) +127%.The9 Limited (NCTY +62% after signing a legally binding cooperation and investment term sheet.Bionano Genomics (BNGO +44% on publishing study on Autism Risk Genes.ViewRay (VRAY +23% on preliminary Q4 results.AirNet Technology (ANTE +28%&#...
Previous 10 Next 10